Download
1-s2.0-S0264410X21005016-main.pdf 1,13MB
WeightNameValue
1000 Titel
  • Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia
1000 Autor/in
  1. MacIntyre, C. Raina |
  2. Costantino, Valentina |
  3. Trent, Mallory |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-04-24
1000 Erschienen in
1000 Quellenangabe
  • Ahead of print
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1016/j.vaccine.2021.04.042 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064825 |
1000 Ergänzendes Material
  • https://www.sciencedirect.com/science/article/pii/S0264410X21005016?via%3Dihub#s0040 |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Several vaccines for SARS-CoV-2 are expected to be available in Australia in 2021. Initial supply is limited and will require a judicious vaccination strategy until supply is unrestricted. If vaccines have efficacy as post-exposure prophylaxis (PEP) in contacts, this provides more policy options. We used a deterministic mathematical model of epidemic response with limited supply (age-targeted or ring vaccination) and mass vaccination for the State of New South Wales (NSW) in Australia. For targeted vaccination, the effectiveness of vaccinating health workers, young people and older adults was compared. For mass vaccination, we tested varying vaccine efficacy (VE) and distribution capacities. With a limited vaccine stockpile enough for 1 million people in NSW, if there is efficacy as PEP, the most efficient way to control COVID-19 will be ring vaccination, however at least 90% of contacts per case needs to be traced and vaccinated. Health worker vaccination is required for health system resilience. Age based strategies with restricted doses make minimal impact on the epidemic, but vaccinating older people prevents more deaths. Herd immunity can only be achieved with mass vaccination. With 90% VE against all infection, herd immunity can be achieved by vaccinating 66% of the population. A vaccine with less than 70% VE cannot achieve herd immunity and will result in ongoing risk of outbreaks. For mass vaccination, distributing at least 60,000 doses per day is required to achieve control. Slower rates of vaccination will result in the population living with COVID-19 longer, and higher cases and deaths.
1000 Sacherschließung
lokal Australia
gnd 1206347392 COVID-19
lokal Vaccines
lokal Epidemic
lokal SARS-CoV-2
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TWFjSW50eXJlLCBDLiBSYWluYQ==|https://frl.publisso.de/adhoc/uri/Q29zdGFudGlubywgVmFsZW50aW5h|https://frl.publisso.de/adhoc/uri/VHJlbnQsIE1hbGxvcnk=
1000 Label
1000 Förderer
  1. National Health and Medical Research Council |
1000 Fördernummer
  1. 1137582
1000 Förderprogramm
  1. Principal Research Fellowship
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Health and Medical Research Council |
    1000 Förderprogramm Principal Research Fellowship
    1000 Fördernummer 1137582
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6429994.rdf
1000 Erstellt am 2021-10-26T15:54:58.442+0200
1000 Erstellt von 218
1000 beschreibt frl:6429994
1000 Bearbeitet von 218
1000 Zuletzt bearbeitet 2022-10-27T08:41:10.345+0200
1000 Objekt bearb. Thu Oct 27 08:41:09 CEST 2022
1000 Vgl. frl:6429994
1000 Oai Id
  1. oai:frl.publisso.de:frl:6429994 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source